INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 20 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-02.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-06-02
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was -657.00 shares.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was -1.35K shares, a 238.76% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 2.02K shares, a 74.03% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 20.00 shares, a 97.29% decline from fiscal 2024.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 737.00 shares, a 95.63% decline from fiscal 2023.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 16.85K shares, a 92.08% decline from fiscal 2022.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 212.60K shares, a 237.37% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | -657.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | -657.00 shares derived: sum of 2 quarters · filed 2026-06-02 | -2.00K shares derived: sum of 3 quarters · filed 2026-06-02 | 20.00 shares 10-K · filed 2026-06-02 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -1.35K shares derived: sum of 2 quarters · filed 2025-11-17 | 677.00 shares 10-Q · filed 2025-11-17 | -7.35K shares derived: sum of 4 quarters · filed 2025-11-17 |
| 2025-06-30 | -1.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 677.00 shares 10-Q · filed 2025-08-14 | -7.35K shares derived: sum of 3 quarters · filed 2025-08-14 | -7.35K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 2.02K shares 10-Q · filed 2025-05-20 | -6.00K shares derived: sum of 2 quarters · filed 2025-05-20 | -6.00K shares derived: sum of 3 quarters · filed 2025-05-20 | -5.03K shares derived: sum of 4 quarters · filed 2025-05-20 |
| 2024-12-31 | -8.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | -8.02K shares derived: sum of 2 quarters · filed 2025-04-30 | -7.05K shares derived: sum of 3 quarters · filed 2025-04-30 | 737.00 shares 10-K · filed 2025-04-30 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-19 | 970.00 shares derived: sum of 2 quarters · filed 2024-11-19 | 8.76K shares 10-Q · filed 2024-11-19 | 14.64K shares derived: sum of 4 quarters · filed 2024-11-19 |
| 2024-06-30 | 970.00 shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-11-19 | 8.76K shares 10-Q/A · filed 2024-11-19 | 14.64K shares derived: sum of 3 quarters · filed 2024-11-19 | 23.26K shares derived: sum of 4 quarters · filed 2024-11-19 |
| 2024-03-31 | 7.79K shares 10-Q · filed 2024-05-15 | 13.67K shares derived: sum of 2 quarters · filed 2024-11-19 | 22.29K shares derived: sum of 3 quarters · filed 2024-11-19 | 1.51K shares derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-12-31 | 5.88K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | 14.50K shares derived: sum of 2 quarters · filed 2024-11-19 | -6.29K shares derived: sum of 3 quarters · filed 2024-11-19 | 16.85K shares 10-K/A · filed 2024-11-19 |
| 2023-09-30 | 8.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -12.16K shares derived: sum of 2 quarters · filed 2023-11-13 | 10.97K shares 10-Q · filed 2023-11-13 | 213.57K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -20.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 2.35K shares 10-Q · filed 2023-08-14 | 204.94K shares derived: sum of 3 quarters · filed 2023-08-14 | |
| 2023-03-31 | 23.13K shares 10-Q · filed 2023-05-15 | 225.73K shares derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2022-12-31 | 202.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | 212.60K shares 10-K · filed 2023-04-17 | ||
| 2022-09-30 | 10.00K shares 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | 63.02K shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |